Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody. (Q34440538)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

based on heuristic

inferred from title

oligodendrocyte

1 reference

based on heuristic

inferred from title

neuromyelitis optica

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Kensuke Ikeda

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Naoki Kiyota

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hiroshi Kuroda

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Shuhei Nishiyama

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Toshiyuki Takahashi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Tatsuro Misu

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ichiro Nakashima

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kazuo Fujihara

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Masashi Aoki

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

25 September 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

656-659

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25257613%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

The spectrum of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1177%2F1352458514551455

21 January 2018

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514551455

21 January 2018

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514551455

21 January 2018

Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study

1 reference

https://api.crossref.org/works/10.1177%2F1352458514551455

21 January 2018

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

1 reference

https://api.crossref.org/works/10.1177%2F1352458514551455

21 January 2018

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

1 reference

https://api.crossref.org/works/10.1177%2F1352458514551455

21 January 2018

Revised diagnostic criteria for neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1177%2F1352458514551455

21 January 2018

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

1 reference

https://api.crossref.org/works/10.1177%2F1352458514551455

21 January 2018

Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease

1 reference

https://api.crossref.org/works/10.1177%2F1352458514551455

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34440538&oldid=1507972668"